IRIS Accounts Production v25.1.3.33 09762403 director 1.10.23 30.9.24 30.9.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh097624032023-09-30097624032024-09-30097624032023-10-012024-09-30097624032022-09-30097624032022-10-012023-09-30097624032023-09-3009762403ns15:EnglandWales2023-10-012024-09-3009762403ns14:PoundSterling2023-10-012024-09-3009762403ns10:Director12023-10-012024-09-3009762403ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3009762403ns10:SmallEntities2023-10-012024-09-3009762403ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3009762403ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3009762403ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3009762403ns10:FullAccounts2023-10-012024-09-300976240312023-10-012024-09-3009762403ns10:RegisteredOffice2023-10-012024-09-3009762403ns5:CurrentFinancialInstruments2024-09-3009762403ns5:CurrentFinancialInstruments2023-09-3009762403ns5:Non-currentFinancialInstruments2024-09-3009762403ns5:Non-currentFinancialInstruments2023-09-3009762403ns5:ShareCapital2024-09-3009762403ns5:ShareCapital2023-09-3009762403ns5:RetainedEarningsAccumulatedLosses2024-09-3009762403ns5:RetainedEarningsAccumulatedLosses2023-09-3009762403ns5:NetGoodwill2023-10-012024-09-3009762403ns5:IntangibleAssetsOtherThanGoodwill2023-10-012024-09-3009762403ns5:PlantMachinery2023-10-012024-09-3009762403ns5:NetGoodwill2023-09-3009762403ns5:NetGoodwill2024-09-3009762403ns5:NetGoodwill2023-09-3009762403ns5:PlantMachinery2023-09-3009762403ns5:PlantMachinery2024-09-3009762403ns5:PlantMachinery2023-09-3009762403ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3009762403ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3009762403ns5:DeferredTaxation2023-09-3009762403ns5:DeferredTaxation2023-10-012024-09-3009762403ns5:DeferredTaxation2024-09-30
REGISTERED NUMBER: 09762403 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2024

FOR

SOPHIE HUNT OSTEOPATHY LIMITED

SOPHIE HUNT OSTEOPATHY LIMITED (REGISTERED NUMBER: 09762403)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


SOPHIE HUNT OSTEOPATHY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2024







DIRECTOR: Mrs S A Elgar





REGISTERED OFFICE: 61 Wagtail Walk
Finberry
Ashford
Kent
TN25 7GE





REGISTERED NUMBER: 09762403 (England and Wales)





ACCOUNTANTS: Cassidys Chartered Accountants
South Stour Offices
South Stour Road
Mersham
Ashford
Kent
TN25 7HS

SOPHIE HUNT OSTEOPATHY LIMITED (REGISTERED NUMBER: 09762403)

BALANCE SHEET
30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £    £   
FIXED ASSETS
Intangible assets 4 47,667 54,167
Tangible assets 5 1,024 1,656
48,691 55,823

CURRENT ASSETS
Debtors 6 3,000 3,157
Cash at bank 10,297 12,507
13,297 15,664
CREDITORS
Amounts falling due within one year 7 49,606 41,241
NET CURRENT LIABILITIES (36,309 ) (25,577 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

12,382

30,246

CREDITORS
Amounts falling due after more than one year 8 (25,193 ) (32,216 )

PROVISIONS FOR LIABILITIES 9 (195 ) (315 )
NET LIABILITIES (13,006 ) (2,285 )

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings (13,007 ) (2,286 )
(13,006 ) (2,285 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

SOPHIE HUNT OSTEOPATHY LIMITED (REGISTERED NUMBER: 09762403)

BALANCE SHEET - continued
30 SEPTEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 22 May 2025 and were signed by:





Mrs S A Elgar - Director


SOPHIE HUNT OSTEOPATHY LIMITED (REGISTERED NUMBER: 09762403)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024


1. STATUTORY INFORMATION

Sophie Hunt Osteopathy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2022, is being amortised evenly over its estimated useful life of ten years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost and 20% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

SOPHIE HUNT OSTEOPATHY LIMITED (REGISTERED NUMBER: 09762403)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Going concern
During the period the company incurred a loss of £5,921 (2023: £4,598) and at the balance sheet date had net liabilities of £13,006 (2023: £2,285). These financial statements have been prepared on a going concern basis which assumes continuing support from the company director and creditors.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 October 2023
and 30 September 2024 65,000
AMORTISATION
At 1 October 2023 10,833
Charge for year 6,500
At 30 September 2024 17,333
NET BOOK VALUE
At 30 September 2024 47,667
At 30 September 2023 54,167

SOPHIE HUNT OSTEOPATHY LIMITED (REGISTERED NUMBER: 09762403)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 October 2023
and 30 September 2024 4,094
DEPRECIATION
At 1 October 2023 2,438
Charge for year 632
At 30 September 2024 3,070
NET BOOK VALUE
At 30 September 2024 1,024
At 30 September 2023 1,656

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Trade debtors - 157
Other debtors 3,000 3,000
3,000 3,157

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Bank loans and overdrafts 7,023 6,620
Taxation and social security 3,000 3,417
Other creditors 39,583 31,204
49,606 41,241

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
30.9.24 30.9.23
£    £   
Bank loans 25,193 32,216

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal - 1,447

SOPHIE HUNT OSTEOPATHY LIMITED (REGISTERED NUMBER: 09762403)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


9. PROVISIONS FOR LIABILITIES
30.9.24 30.9.23
£    £   
Deferred tax 195 315

Deferred
tax
£   
Balance at 1 October 2023 315
Provided during year (120 )
Balance at 30 September 2024 195

10. RELATED PARTY DISCLOSURES

During the year, total dividends of £16,500 (2023 - £11,800) were paid to the director .

Mrs S A Elgar - Director and Shareholder

At the balance sheet date Sophie Hunt Osteopathy Ltd owed Mrs Elgar £21,662 (2023 - the company owed Mrs Elgar £13,284).